MYGN

Myriad Genetics, Inc.

24.20 USD
-0.06 (-0.25%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Myriad Genetics, Inc. stock is up 4.49% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 41.38% of the previous 28 June’s closed higher than May. In the last 8 Unusual Options Trades, there were 3 PUTs, 5 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
24 Apr 19:51 15 Nov, 2024 21.00 PUT 98 0
07 May 19:57 17 May, 2024 18.00 PUT 700 46
08 May 16:31 21 Jun, 2024 20.00 CALL 81 1
08 May 16:32 21 Jun, 2024 20.00 CALL 155 1
08 May 16:53 21 Jun, 2024 20.00 CALL 100 1
08 May 19:47 21 Jun, 2024 20.00 CALL 93 1
03 Jun 16:27 19 Jul, 2024 20.00 CALL 245 0
21 Jun 19:12 19 Jul, 2024 22.00 PUT 700 2

About Myriad Genetics, Inc.

Myriad Genetics, Inc. develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers.